(Q39351483)

11 September 2017

Pharmacokinetics, tissue distribution and anti-tumour efficacy of paclitaxel delivered by polyvinylpyrrolidone solid dispersion (English)

1 reference

11 September 2017

1 reference

1 reference

Xiangrui Liu

1

1 reference

11 September 2017

Jiabei Sun

2

1 reference

11 September 2017

Xiaomei Chen

3

1 reference

11 September 2017

Shanshan Wang

4

1 reference

11 September 2017

Hannah Scott

5

1 reference

11 September 2017

Xuan Zhang

6

1 reference

11 September 2017

Qiang Zhang

7

1 reference

11 September 2017

language of work or name

1 reference

27 February 2012

1 reference

Journal of Pharmacy and Pharmacology

11 September 2017

1 reference

11 September 2017

64

1 reference

11 September 2017

6

1 reference

11 September 2017

775-782

1 reference

Taxol: a novel investigational antimicrotubule agent

11 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01471.X

Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01471.X

Hypersensitivity reactions to teniposide (VM-26): an analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01471.X

Toxicity studies of cremophor-free paclitaxel solid dispersion formulated by a supercritical antisolvent process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01471.X

Paclitaxel in cancer treatment: perspectives and prospects of its delivery challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01471.X

Phase I and pharmacokinetic study of AI-850, a novel microparticle hydrophobic drug delivery system for paclitaxel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01471.X

Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01471.X

Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01471.X

Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01471.X

Intravenous hydrophobic drug delivery: a porous particle formulation of paclitaxel (AI-850).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01471.X

Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01471.X

Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01471.X

Quantitation of Cremophor EL in human plasma samples using a colorimetric dye-binding microassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01471.X

Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01471.X

Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01471.X

Paclitaxel pharmacokinetics, threshold models, and dosing strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01471.X

Histamine release in dogs by Cremophor El® and its derivatives: Oxethylated oleic acid is the most effective constituent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01471.X

21 January 2018

The taxanes: an update

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01471.X

10.1111/J.2042-7158.2012.01471.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference